Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Market Cap
$1.38B
P/E Ratio
-7.73
1Y Stock Return
-35.46%
1Y Revenue Growth
-3.03%
Dividend Yield
0.00%
Price to Book
3.1
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
NEW YORK, November 20, 2024--Schrödinger today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference.
Finnhub
NEW YORK - Schrodinger, Inc. today reported that on November 14, 2024, the company granted restricted stock units with respect to 2,785 shares of the company's common stock to four newly hired...
Yahoo
NEW YORK, November 19, 2024--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on November 14, 2024, the company granted restricted stock units (RSUs) with respect to 2,785 shares of the company’s common stock to four newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material induceme
Yahoo
NEW YORK, November 18, 2024--Schrödinger broadens and accelerates predictive toxicology initiative.
Yahoo
Schrödinger ( NASDAQ:SDGR ) Third Quarter 2024 Results Key Financial Results Revenue: US$35.3m (down 17% from 3Q 2023...
Yahoo
Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development candidates into Novartis’s portfolio for further development. The companies also announced an expanded three-year software agreement that substantially increases Novartis’s access to Schrodinger’s computational predictive modeling technology and enterprise informatics platform. This expanded access enables Novartis to deploy Schrodinger’s full suite of drug discov
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KN | 55.09% | $1.60B | +12.19% | 0.00% |
CRL | 54.08% | $9.52B | -3.20% | 0.00% |
DIOD | 50.60% | $2.53B | -20.36% | 0.00% |
PCOR | 50.34% | $10.41B | +26.77% | 0.00% |
OLO | 49.99% | $1.06B | +30.00% | 0.00% |
BEAM | 49.80% | $2.09B | -9.52% | 0.00% |
XMTR | 49.37% | $1.48B | +50.13% | 0.00% |
GOLF | 48.89% | $4.21B | +20.68% | 1.22% |
ENOV | 48.68% | $2.53B | -10.59% | 0.00% |
SYNA | 48.27% | $2.91B | -29.84% | 0.00% |
PAX | 48.05% | $1.83B | -15.48% | 8.96% |
AZTA | 47.81% | $2.00B | -28.24% | 0.00% |
CNXN | 47.70% | $1.84B | +14.37% | 0.57% |
NTLA | 47.63% | $1.44B | -50.35% | 0.00% |
IQV | 47.51% | $34.73B | -7.77% | 0.00% |
LC | 47.40% | $1.69B | +175.00% | 0.00% |
DMRC | 47.34% | $694.39M | -2.06% | 0.00% |
RCKY | 47.20% | $155.86M | -17.74% | 2.95% |
SLP | 47.06% | $554.26M | -28.05% | 0.66% |
KLIC | 46.77% | $2.46B | -8.18% | 1.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -21.68% | $78.15B | +35.51% | 0.42% |
RNR | -16.64% | $13.74B | +23.09% | 0.58% |
ACGL | -14.85% | $36.00B | +16.84% | 0.00% |
HRL | -13.51% | $16.30B | -8.38% | 3.81% |
PGR | -11.48% | $149.10B | +57.29% | 0.45% |
CBOE | -11.37% | $21.46B | +15.84% | 1.11% |
EG | -10.06% | $15.92B | -8.98% | 2.02% |
NHTC | -9.82% | $61.83M | +0.19% | 14.81% |
LMT | -9.57% | $126.40B | +18.99% | 2.36% |
HUSA | -9.31% | $16.69M | -11.56% | 0.00% |
CHD | -9.27% | $27.18B | +19.50% | 1.03% |
PULM | -8.55% | $19.83M | +202.98% | 0.00% |
APRE | -8.25% | $16.41M | -19.47% | 0.00% |
COR | -8.22% | $47.48B | +21.20% | 0.86% |
CME | -7.73% | $82.76B | +9.21% | 1.98% |
NOC | -6.78% | $71.54B | +4.23% | 1.60% |
CYD | -6.33% | $364.46M | -2.94% | 4.26% |
GIS | -6.01% | $34.85B | -2.91% | 3.78% |
VIRT | -5.57% | $3.17B | +110.38% | 2.60% |
TPST | -5.41% | $37.75M | -77.59% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -50.62% | $388.04M | 1.43% |
VIXY | -29.28% | $195.31M | 0.85% |
TAIL | -20.67% | $67.98M | 0.59% |
USDU | -18.15% | $201.97M | 0.5% |
CLOI | -15.42% | $715.40M | 0.4% |
UUP | -14.71% | $309.25M | 0.77% |
JUCY | -8.73% | $324.29M | 0.6% |
CTA | -8.50% | $350.27M | 0.78% |
AGZD | -7.70% | $142.76M | 0.23% |
TPMN | -7.58% | $40.60M | 0.65% |
WEAT | -6.40% | $120.27M | 0.28% |
KMLM | -6.34% | $353.87M | 0.9% |
EQLS | -5.11% | $76.08M | 1% |
CORN | -3.94% | $61.12M | 0.2% |
HDRO | -2.35% | $164.26M | 0.3% |
BILZ | -2.32% | $563.02M | 0.14% |
MINT | -2.06% | $11.62B | 0.35% |
HIGH | -1.95% | $302.78M | 0.51% |
XHLF | -1.62% | $874.27M | 0.03% |
DBA | -1.08% | $755.88M | 0.93% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MSDL | -0.05% | $1.83B | +0.66% | 7.26% |
ALL | -0.07% | $52.06B | +45.67% | 1.85% |
CPSH | -0.08% | $20.70M | -40.13% | 0.00% |
PRDO | -0.19% | $1.73B | +56.77% | 1.74% |
IMMP | 0.25% | $293.82M | +8.31% | 0.00% |
NNVC | 0.26% | $19.66M | +25.69% | 0.00% |
CAH | -0.39% | $28.64B | +12.14% | 1.70% |
MANU | -0.39% | $2.88B | -9.41% | 0.00% |
GEL | 0.45% | $1.44B | +2.81% | 5.24% |
LRN | 0.49% | $4.43B | +74.97% | 0.00% |
WRB | 0.54% | $22.94B | +29.98% | 0.69% |
TW | 0.58% | $28.66B | +42.39% | 0.29% |
NEUE | 0.58% | $40.93M | -34.13% | 0.00% |
SYPR | 0.69% | $32.23M | -26.32% | 0.00% |
QNTM | 0.74% | $9.19M | -94.36% | 0.00% |
QXO | 0.76% | $6.51B | -35.95% | 0.00% |
TMUS | 0.78% | $270.63B | +56.92% | 0.83% |
SRRK | 0.79% | $2.61B | +134.91% | 0.00% |
PRPO | 0.83% | $9.10M | -13.65% | 0.00% |
RILY | 0.88% | $145.72M | -79.86% | 20.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 64.64% | $1.13B | 0.75% |
GNOM | 60.14% | $70.59M | 0.5% |
IWR | 58.33% | $39.67B | 0.19% |
RSPA | 57.41% | $273.87M | 0% |
QCLN | 56.42% | $574.08M | 0.59% |
ISCG | 56.32% | $640.00M | 0.06% |
XBI | 55.99% | $6.58B | 0.35% |
ACES | 55.22% | $124.79M | 0.55% |
PRNT | 55.17% | $95.35M | 0.66% |
IBB | 54.78% | $6.66B | 0.45% |
NUSC | 54.73% | $1.27B | 0.31% |
IWC | 54.61% | $933.99M | 0.6% |
ESML | 54.52% | $1.90B | 0.17% |
VBK | 54.48% | $19.31B | 0.07% |
KOMP | 54.33% | $2.09B | 0.2% |
IWO | 54.22% | $12.56B | 0.24% |
VXF | 54.05% | $21.54B | 0.06% |
PTH | 54.04% | $143.31M | 0.6% |
SMMD | 54.00% | $1.24B | 0.15% |
IWM | 53.96% | $75.73B | 0.19% |
Current Value
$18.941 Year Return
Current Value
$18.941 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UNG | -0.05% | $908.80M | 1.06% |
IVOL | 0.18% | $548.70M | 1.02% |
TBLL | -0.25% | $1.92B | 0.08% |
BSCO | -0.58% | $2.35B | 0.1% |
XBIL | -0.59% | $637.70M | 0.15% |
SHV | 0.83% | $18.13B | 0.15% |
KRBN | 0.84% | $242.47M | 0.85% |
BOXX | 0.95% | $4.43B | 0.1949% |
DBE | 1.07% | $50.13M | 0.77% |
DBA | -1.08% | $755.88M | 0.93% |
DBO | 1.52% | $217.57M | 0.77% |
XHLF | -1.62% | $874.27M | 0.03% |
KCCA | 1.89% | $220.51M | 0.87% |
HIGH | -1.95% | $302.78M | 0.51% |
MINT | -2.06% | $11.62B | 0.35% |
BILZ | -2.32% | $563.02M | 0.14% |
HDRO | -2.35% | $164.26M | 0.3% |
SGOV | 2.42% | $27.53B | 0.09% |
XONE | 2.61% | $548.88M | 0.03% |
CSHI | 2.65% | $482.85M | 0.38% |